Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

Multiple Choice

Which condition is a major etiologic factor for cirrhosis and is also a leading cause of liver disease in the Western world due to metabolic syndrome?

Nonalcoholic fatty liver disease (NAFLD), encompassing its inflammatory form nonalcoholic steatohepatitis (NASH), is the condition being tested. It links metabolic syndrome—obesity, insulin resistance, dyslipidemia, and hypertension—to fat accumulation in the liver. In many individuals this fat deposition stays simple, but a subset develops inflammation and hepatocellular injury (NASH), which can progress to fibrosis and ultimately cirrhosis. Because obesity and metabolic syndrome have become so widespread in Western populations, NAFLD/NASH has emerged as a major and now leading cause of chronic liver disease and cirrhosis, surpassing other etiologies in many settings. The underlying mechanism centers on insulin resistance driving excess fatty acids to the liver, promoting steatosis; this triggers oxidative stress and inflammatory pathways that activate fibrogenesis. The other choices are less closely tied to metabolic syndrome and are not the primary driver of cirrhosis in the Western world.

Nonalcoholic fatty liver disease (NAFLD), encompassing its inflammatory form nonalcoholic steatohepatitis (NASH), is the condition being tested. It links metabolic syndrome—obesity, insulin resistance, dyslipidemia, and hypertension—to fat accumulation in the liver. In many individuals this fat deposition stays simple, but a subset develops inflammation and hepatocellular injury (NASH), which can progress to fibrosis and ultimately cirrhosis. Because obesity and metabolic syndrome have become so widespread in Western populations, NAFLD/NASH has emerged as a major and now leading cause of chronic liver disease and cirrhosis, surpassing other etiologies in many settings. The underlying mechanism centers on insulin resistance driving excess fatty acids to the liver, promoting steatosis; this triggers oxidative stress and inflammatory pathways that activate fibrogenesis. The other choices are less closely tied to metabolic syndrome and are not the primary driver of cirrhosis in the Western world.